359 related articles for article (PubMed ID: 27038510)
1. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways.
Rabinovich GA; Conejo-García JR
J Mol Biol; 2016 Aug; 428(16):3266-3281. PubMed ID: 27038510
[TBL] [Abstract][Full Text] [Related]
2. Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis.
Méndez-Huergo SP; Blidner AG; Rabinovich GA
Curr Opin Immunol; 2017 Apr; 45():8-15. PubMed ID: 28088061
[TBL] [Abstract][Full Text] [Related]
3. Re-wiring regulatory cell networks in immunity by galectin-glycan interactions.
Blidner AG; Méndez-Huergo SP; Cagnoni AJ; Rabinovich GA
FEBS Lett; 2015 Nov; 589(22):3407-18. PubMed ID: 26352298
[TBL] [Abstract][Full Text] [Related]
4. Untangling Galectin-Driven Regulatory Circuits in Autoimmune Inflammation.
Toscano MA; Martínez Allo VC; Cutine AM; Rabinovich GA; Mariño KV
Trends Mol Med; 2018 Apr; 24(4):348-363. PubMed ID: 29555188
[TBL] [Abstract][Full Text] [Related]
5. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
[TBL] [Abstract][Full Text] [Related]
6. Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment.
Elola MT; Ferragut F; Méndez-Huergo SP; Croci DO; Bracalente C; Rabinovich GA
Cell Immunol; 2018 Nov; 333():34-45. PubMed ID: 29602445
[TBL] [Abstract][Full Text] [Related]
7. Study of galectins in tumor immunity: strategies and methods.
Cerliani JP; Dalotto-Moreno T; Compagno D; Dergan-Dylon LS; Laderach DJ; Gentilini L; Croci DO; Méndez-Huergo SP; Toscano MA; Salatino M; Rabinovich GA
Methods Mol Biol; 2015; 1207():249-68. PubMed ID: 25253145
[TBL] [Abstract][Full Text] [Related]
8. The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy.
Yang R; Hung MC
Sci China Life Sci; 2017 Oct; 60(10):1058-1064. PubMed ID: 29027155
[TBL] [Abstract][Full Text] [Related]
9. Assembly, organization and regulation of cell-surface receptors by lectin-glycan complexes.
Elola MT; Blidner AG; Ferragut F; Bracalente C; Rabinovich GA
Biochem J; 2015 Jul; 469(1):1-16. PubMed ID: 26173257
[TBL] [Abstract][Full Text] [Related]
10. Galectins in the Tumor Microenvironment: Focus on Galectin-1.
Martínez-Bosch N; Navarro P
Adv Exp Med Biol; 2020; 1259():17-38. PubMed ID: 32578169
[TBL] [Abstract][Full Text] [Related]
11. Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma.
Pace A; Scirocchi F; Napoletano C; Zizzari IG; D'Angelo L; Santoro A; Nuti M; Rahimi H; Rughetti A
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682991
[TBL] [Abstract][Full Text] [Related]
12. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer.
Rabinovich GA; Croci DO
Immunity; 2012 Mar; 36(3):322-35. PubMed ID: 22444630
[TBL] [Abstract][Full Text] [Related]
13. The universe of galectin-binding partners and their functions in health and disease.
Troncoso MF; Elola MT; Blidner AG; Sarrias L; Espelt MV; Rabinovich GA
J Biol Chem; 2023 Dec; 299(12):105400. PubMed ID: 37898403
[TBL] [Abstract][Full Text] [Related]
14. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.
Salatino M; Rabinovich GA
Methods Mol Biol; 2011; 677():355-74. PubMed ID: 20941621
[TBL] [Abstract][Full Text] [Related]
15. Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma.
Videla-Richardson GA; Morris-Hanon O; Torres NI; Esquivel MI; Vera MB; Ripari LB; Croci DO; Sevlever GE; Rabinovich GA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008740
[TBL] [Abstract][Full Text] [Related]
16. Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity.
Cerliani JP; Stowell SR; Mascanfroni ID; Arthur CM; Cummings RD; Rabinovich GA
J Clin Immunol; 2011 Feb; 31(1):10-21. PubMed ID: 21184154
[TBL] [Abstract][Full Text] [Related]
17. Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.
Lau LS; Mohammed NBB; Dimitroff CJ
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555198
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
Nicholas NS; Apollonio B; Ramsay AG
Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
[TBL] [Abstract][Full Text] [Related]
19. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.
Rabinovich GA; Toscano MA
Nat Rev Immunol; 2009 May; 9(5):338-52. PubMed ID: 19365409
[TBL] [Abstract][Full Text] [Related]
20. Translating the 'Sugar Code' into Immune and Vascular Signaling Programs.
Cerliani JP; Blidner AG; Toscano MA; Croci DO; Rabinovich GA
Trends Biochem Sci; 2017 Apr; 42(4):255-273. PubMed ID: 27986367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
